Skip to main content

Table 1 Clinical characteristics of subjects in cross sectional study

From: Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B

Group

HC

IT

CHB

IC

No. of patients

22

28

29

33

Gender(M/F)

12/10

10/18

18/11

19/14

Age(year)

25.0 (22.2-33.8)

26.0 (17.4-36.2)

27.0 (22.0-38.0)

33.0 (22.0-43.8)

HBV-DNA(log10 copies/mL)

n.d.

8.00 (6.41-9.30)

7.98 (6.57-9.02)

<3

ALT(U/L)

14.5 (8.3-27.9)

26.0(15.6-35.0)

104.2(60.6-214.0)

19(12–30.8)

HBsAg positive

0

28

29

33

Anti-HBs positive

16

0

0

0

HBeAg positive

0

28

29

0

Anti-HBe positive

0

0

0

33

Anti-HBc positive

0

28

29

33

  1. Data are shown as median (10–90% percentile).
  2. ALT, alanine aminotransferase; CHB, chronic hepatitis B; HC, healthy control; IC, inactive carrier; IT, immune tolerant;
  3. HBsAg, hepatitis B surface (HBs) antigen; HBeAg, hepatitis B e antigen; n.d., not determined.